Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “RADIOACTIVITY”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,585 records · Page 88Linked to original sources

An experience of the use of radioactive plaques after failure of external beam radiation in the treatment of retinoblastoma.

The authors have reviewed the results of radioactive plaques in recurrent retinoblastoma after external beam radiation in 34 eyes. They give their results on ocular conservation and on the visual outcome and compare these results with other series previously published. They think radioactive plaques are an alternative to enucleation in recurrent retinoblastoma after external beam.

Brachytherapy↗

Synoviorthesis with radioactive gold in hemophiliacs. Clinical and radiological follow-up.

Twenty-seven patients with hemophilia treated with intra-articular injection of radioactive gold were followed up clinically and radiologically for 3 to 9 years after treatment. To assess the radiological changes, a new classification was designed, with a score describing the severity of the changes in a more accurate manner than the methods previously used. The treatment decreased the bleeding frequency and stopped the progress of the arthropathy if applied at an early stage when the arthropathy was still reversible. If the treatment was begun at a later stage, the arthropathy seemed to progress independently of the effect on the bleeding frequency. No negative effect of the radioactive gold was observed on the joint or the growing zone.

Adolescent↗

Rapid determination of (carbon-14) glucose specific radioactivity for in vivo glucose kinetics.

Specific radioactivity of blood glucose was determined by use of a Dowex-1 anion-exchange column after (carbon-14) glucose was infused for in vivo kinetics. The first 20-ml eluate of protein-free blood filtrate from the column was discarded; then 10 ml was collected, lyophilized, and counted in a liquid-scintillation counter. Glucose concentration was determined and specific radioactivity calculated. Kinetic results were comparable to those obtained with the more laborious glucose-pentaacetate procedure.

Acetates↗

Rapid and specific isolation of radioactive glucose from biological samples.

An easy, reliable, and specific ion-exchange method is presented for isolating glucose for specific radioactivity determinations from both blood plasma and buffered in vitro incubation media. The use of a glucose binding resin (borate-charged anion resin) combined speed of ion exchange with specificity of derivative formation. Glucose specific radioactivities, determined by ion exchange on protein-free filtrates of plasma containing [carbon-14] glucose, show excellent agreement with those from the popular glucose pentaacetate derivative method and are less variable. Carry-over of labeled acetate, propionate, lactate, glyoxylate, alanine, aspartate, or glutamate into the glucose fraction is less than .2%. Glycerol carryover is 1.2%. Glucose recovery is increased about three times that of the glucose pentaacetate derivative method and averaged 94% from plasma filtrates.

Animals↗

Intestinal absorption of riboflavin, studied by an in situ circulation system using radioactive analogues.

The intestinal absorption of riboflavin was studied using radioactive riboflavin and its analogues 8-demethylriboflavin, 3-methylriboflavin, 5'-deoxyriboflavin, 2'-deoxyriboflavin, 7,8-dimethyl-10-hydroxyethylisoalloxazine, lumiflavin, lumichrome, and riboflavin-5'-monosulfate, which were synthesized with high specific radioactivity. A specific absorption of riboflavin at dietary concentrations was confirmed using an in situ circulation system. The relation between the chemical structure of flavins and the absorption mechanism was studied using this system. The 8-demethylriboflavin, an analogue modified at benzene moiety of the isoalloxazine ring, was absorbed in a similar way to riboflavin, by dual kinetics: by a process specific for riboflavin at dietary concentrations and by simple diffusion (nonspecific absorption) predominating at higher concentrations (over 100 microM). However, 3-methylriboflavin and analogues modified at the ribityl group, including 5'-deoxyriboflavin, were absorbed only via simple diffusion even at dietary concentrations. Many flavins examined, except for 3-isobutylriboflavin, 3-carboxymethylriboflavin, lumichrome, and riboflavin-5'-monosulfate, interfered with the specific absorption of riboflavin. It was concluded from these results that one of the specific absorption processes for riboflavin is a phosphorylation-dephosphorylation process. Four water-soluble vitamins did not interfere with the specific absorption of riboflavin, indicating that these vitamins do not share a common specific absorption pathway with riboflavin.

Animals↗

[Residual radioactivity measurement for high purity silicon irradiated by pile-neutron (author's transl)].

Residual radioactivity measurement is described for high purity silicon (purer than tennine) irradiated by pile-neutron to produce n-type silicon semiconductor. The silicon samples were irradiated in four different atomic reactors with thermal neutron fluxes of 0.12, 1.48, 1.8 and 5.5 X 10(13) n/cm2. sec. After irradiation, the sample was dissolved in HF-HNO3, and the solution dried. The residual radioactivity was measured by a 2pi gas-flow low background GM counter. The only active species found was 32P, which was formed by the consecutive reaction of 30Si(n, gamma)31Si beta- leads to 31P followed by 31P(N, GAMMA)32P. The observed production rate for 32P was in good agreement with the calculated one. This technique can be applied to estimate amounts of not only doped phosphorus but impurities such as gold in irradiated silicon. Tail part of a float-zone silicon rod contained about 0.01 atomic ppb of Au, but no activity was observed in its middle part. The present technique is suitable for checking and characterizing silicon rods before their neutron-doping.

Neutrons↗

[The gamma ray peak efficiency determination for volume samples using a radioactive point source (author's transl)].

The peak efficiencies for volume samples in gamma spectrometry of environmental radioactive materials have been determined using a radioactive standard point source. The advantages of the method, as compared with conventional calibration method using standard volume sources, are as follows; 1) The peak efficiencies can be obtained with high accuracy and precision, 2) To be applied easily to any sample container being axial symmetry, 3) The correction for self-absorption can be performed by the simple calculation. On the other hand, the application of the method is restricted to only the cylindrical or coaxial detector.

Mathematics↗

[Fundamental studies for the development of pancreas scanning agents--preparation of radioactive iodine-labeled amino acids and peptides and their distribution (author's transl)].

75Se-Selenomethionine is often used for the isotope scanning of pancreas. However, it is desired to develop excellent pancreas scanning agens that give more specific distribution and less radiation hazards than the agents. Pancreas has a high ability to incorporate amino acids into its cells and to utilize the acids for the synthesis off proteins and enzymes. On the basis of this preferential uptake of amino acids, radioactive iodine-labeled amino acids and peptides, gamma-131I-iodo-alpha-aminobutyric acid, N-2-131I-monoiodoacetyl-L- and D-leucines, L- and D-leucine 2-131I-iodoethyl esters, 125I or 131I-labeled dipeptides, and insulin 125I-A and 131I-B chains, were prepared and assayed for their distribution in mouse organs and Ehrlich ascites tumor cells. Radioactivity of these labeled compounds incorporated into pancreas was almost the same as that of liver and spleen, and considerably smaller than that of stomach, duodenum and kidney. Since a high incorporation into stomach was seen also after the administration of 125I-sodium iodide, it was suggested that iodine ions were liberated in vivo from the labeled compounds within a short time.

Amino Acids↗

Thallium-201 radioactive implant induced X-ray emission scanning of stable iodine distribution in thyroid--phantom experiment.

A new method has been developed for imaging the thyroid gland by the use of 201Tl radioactive implant induced X-ray emission (RIXE). The thyroid phantom was made from two cylindrical tubes embedded in plastic neck phantom. Each tube consisted of stable iodine and 201Tl radioactive source in 10 ml water solution. Some photopeaks in the energy range from 20 to 200 ke V were scanned along a horizontal axis by the collimated Ge detector with high energy resolution. The distribution on the horizontal axis was obtained for the generated I K alpha-ray and some primary 201Tl radiations. The 201Tl RIXE scanning can provide information about the distribution of iodine with 201Tl as well as 201Tl distribution in the thyroid gland. The effectiveness of the 201Tl RIXE technique as a thyroid scanning method is discussed.

Iodine↗

[Evaluation of additional absorbed radiation dose from radioactive impurities in radiopharmaceuticals].

The additional absorbed radiation doses to total body from radioactive impurities in radiopharmaceuticals were estimated for a total of 10 samples (i.e., 99mTc generator eluates, 99mTc solutions, 67Ga, 81mKr generator eluates, 111In, 123I, 201Tl, 75Se, 197Hg, 198Au) selected from commonly used radiopharmaceuticals. The radioactive impurities in radiopharmaceuticals used in this estimation were previously identified. The radiation doses were calculated according to the MIRD procedures, assuming each radionuclide to be uniformly distributed throughout the body. In the case of the cyclotron-produced radioisotopes and 198Au, the additional total body absorbed doses from impurities were found to be rather high: 280% for 123I, 55% for 81mKr, 5% for 198Au, 4% for 111In and 2% for 201Tl. The absorbed doses due to impurities in the other radioisotopes were less than 1%.

Drug Contamination↗

A comparison of non-radioactive labeling and detection systems with synthetic oligonucleotide probes for the species identification of mosquitoes in the Anopheles gambiae complex.

Different non-radioactive probe labeling and detection systems were used with pAnaI, a species-specific oligonucleotide probe that distinguishes male Anopheles gambiae and An. arabiensis mosquitoes. Comparisons have been made between the performance of each technique with respect to sensitivity and specificity against DNA dot-blots and mosquito squashes. Their relative costs, economy, and ease of use were analyzed in an attempt to develop an appropriate non-radioactive system for use in the field. Enzyme-labeled probes that were detected directly by label activity proved more suitable than probes requiring reporter molecules for detection. Binding of reporter molecules to mosquito squashes caused the appearance of false positives and, in addition, their binding to nylon filters caused high background coloration. Chemiluminescent detection provided an attractive alternative to colorimetric detection. Both systems analyzed were rapid, simple, and economic. However, less severe treatment of filters was required for reprobing with chemiluminescence. The greatest sensitivity achieved was with chemiluminescent detection in which the limit of detection was 0.15 ng of target DNA. This study suggests that a synthetic DNA probe coupled to a chemiluminescent detection system should provide a sufficiently simple, sensitive, and reliable technique for insect vector identification in the field.

Animals↗

The needs of family members of patients receiving radioactive iodine.

The current literature on radionuclide therapy is heavily based on health care professionals' perspectives and provides little insight regarding what patients or family members identify as their needs or concerns. Family members (N = 130) of patients undergoing treatment with radioactive iodine were selected from eight programs across Canada to participate in a survey to identify the needs they had when a close relative was undergoing treatment with radioactive iodine. The results of the survey indicated family members experienced worries and concerns about the patient being at home after treatment, and there was variation in their knowledge about what precautions were needed. Family members provided evidence that many experienced psychosocial distress, but very few received adequate assistance for their difficulties.

Adult↗

Criteria for the release of individuals administered radioactive materials--NRC. Final rule.

The Nuclear Regulatory Commission (NRC) is amending its regulations concerning the criteria for the release of patients administered radioactive material. The new criteria for patient release are based on the potential dose to other individuals exposed to the patient. The new criteria are consistent with the recommendations of the National Council on Radiation Protection and Measurements (NCRP) and the International Commission on Radiological Protection (ICRP). This final rule required the license to provide written instructions to patients on how to maintain the doses to others as low as is reasonably achievable if the total effective dose equivalent to any other individual exposed to the released patient is likely to exceed 1 milisievert (0.1 rem). This final rule responds to three petitions for rulemaking regarding the criteria for release of patients administered radioactive material.

Guidelines as Topic↗

Exempt distribution of a radioactive drug containing one microcurie of carbon-14 urea--NRC. Final rule.

The Nuclear Regulatory Commission (NRC) is amending its regulations to permit NRC licensees to distribute a radioactive drug containing one microcurie of carbon-14 urea to any person for "in vivo" diagnostic use. The NRC has determined that the radioactive component of such a drug in capsule form presents an insignificant radiation risk and, therefore, regulatory control of the drug for radiation safety is not necessary. This amendment makes the drug more widely available and reduces costs to patients, insurers, and the health care industry. This action grants a petition for rulemaking (PRM-35-12) from Tri-Med Specialties, Inc. and completes action on the petition.

Carbon Radioisotopes↗

Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body.

UNLABELLED: Accurate determination of red marrow radiation is important because myelotoxicity is often dose limiting in radioimmunotherapy. The S-value methodology assumes a fixed red marrow mass as defined by the standard Medical Internal Radiation Dose (MIRD) mathematic phantom. Substantial error can be introduced in marrow radiation estimates because red marrow mass varies from patient to patient. In this work we describe a patient-specific marrow dosimetry methodology that does not require an explicit estimate of marrow mass. METHODS: Photon radiation to marrow from all sources can be considered as the total body to marrow. Based on photon radiation from body and electron radiation from blood, a patient-specific marrow dose can be determined by counting blood and total body radioactivity and measuring body weight. RESULTS: The deviation in marrow dose calculation using total body to represent all photon radiation was 3.9% in 66 patients administered 131I-labeled antibodies and was 9.1% in 18 patients administered 67Cu-labeled antibodies. The differences between this patient-specific approach and estimates based on standard anatomy were considerable, ranging from -35% to 88%. The differences were greater when patients' weights differed substantially from the MIRD reference man phantom. CONCLUSION: For radiopharmaceuticals that do not bind marrow, patient-specific marrow dosimetry can be independent of the actual marrow mass of a patient. Patient-specific marrow dosimetry can be determined using radioactivity concentration in blood and body.

Body Weight↗

Nonradioactive northern blotting for the determination of acetylcholinesterase mRNA. Comparison to the radioactive technique.

A sensitive nonradioactive northern blotting for the detection of acetylcholinesterase mRNA in mammalian tissues is described and compared to its radioactive version. Best results were obtained if digoxigenin labeled RNA probe was used for hybridization and CDP-Star, a chemiluminescent alkaline phosphatase substrate, for detection. The described nonradioactive technique for acetylcholinesterase mRNA determination is as sensitive as the radioactive one, but requires no protection against radiation and is less time consuming. Because of higher stability of the labeled probe, nonradioactive technique is also more convenient from the standpoint of experimental planning.

Acetylcholinesterase↗

[Thyroiditis induced by radioactive iodine (I-131). Report of a case and review of the literature].

A 23 years old female with Graves' disease initiated a symptomatic treatment with propanolol and then received radioactive iodine (I-311) 370 MBq (10 mCi) as definitive treatment. Three weeks later she was hospitalized because she presented acute radiation thyroiditis. She was discharged after 48 h of treatment, but clinical symptoms and signs persisted for over 30 days, but in less degree. One month later she developed hypothyroidism. There are three therapeutics options for the treatment of Grave's disease (antithyroid drugs, radioiodine and surgery). There are some hospitals in which the use of radioactive iodine is preferred as the first option, without a pretreatment with antithyroid drugs, but this could lead to acute thyroiditis or thyroid storm.

Adult↗

Radioactive contamination of packing materials from a xenon-133 shipment.

OBJECTIVE: We report on radioactive contamination of packing materials from a 133Xe shipment. METHODS: A 2-vial 133Xe shipment was monitored using a survey meter before opening. Both vials were immediately assayed in a dose calibrator. The packing materials were monitored and contamination was detected. RESULTS: The maximum surface reading of the shipment was 7.0 microSv/h. This was higher than previous shipments (1.1 +/- 0.3 microSv/h). One vial was 544 MBq while the other vial was only 474 MBq. Previous shipments were 565 +/- 13 MBq/vial. Monitoring and imaging revealed 133Xe contamination within the packing materials. Xenon-133 escaped from the packing materials over time. The lower activity vial continued to leak 133Xe over time. CONCLUSION: Careful monitoring of 133Xe shipments before and after opening along with assaying vials on receipt can indicate vial leakage and radioactive contamination so steps can be taken to minimize radiation exposure to the staff.

Humans↗